Christophe Henry

Person

Munchen, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted imidazoquinolines
- Patent number 12,054,485
- Issue date Aug 6, 2024
- BIONTECH SE
- Christophe Henry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted imidazoquinolines as agonists of TLR7
- Patent number 11,987,569
- Issue date May 21, 2024
- BIONTECH SE
- Christophe Henry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted imidazoquinolines as agonists of TLR7
- Patent number 11,279,684
- Issue date Mar 22, 2022
- Bointech SE
- Christophe Henry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted imidazoquinolines
- Patent number 11,267,813
- Issue date Mar 8, 2022
- BioNTech SE
- Christophe Henry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Arylsulfonylmethyl or arylsulfonamide substituted aromatic compound...
- Patent number 8,969,552
- Issue date Mar 3, 2015
- AbbVie Deutschland GmbH and Co KG
- Karla Drescher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds suitable for treating disorders that respond...
- Patent number 8,470,810
- Issue date Jun 25, 2013
- Abbott GmbH & Co. KG
- Karla Drescher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds suitable for treating disorders that respond...
- Patent number 7,851,463
- Issue date Dec 14, 2010
- Abbott GmbH & Co. KG
- Karla Drescher
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SUBSTITUTED IMIDAZOQUINOLINES AS AGONISTS OF TLR7
- Publication number 20220242845
- Publication date Aug 4, 2022
- BIONTECH SE
- Christophe HENRY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED IMIDAZOQUINOLINES
- Publication number 20220227756
- Publication date Jul 21, 2022
- BIONTECH SE
- Christophe HENRY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESS FOR THE PREPARATION OF A SUBSTITUTED IMIDAZOQUINOLINE
- Publication number 20220144822
- Publication date May 12, 2022
- BIONTECH SE
- Christophe HENRY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED IMIDAZOQUINOLINES AS AGONISTS OF TLR7
- Publication number 20210002249
- Publication date Jan 7, 2021
- BIONTECH SE
- Christophe HENRY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED IMIDAZOQUINOLINES
- Publication number 20200317663
- Publication date Oct 8, 2020
- BIONTECH SE
- Christophe HENRY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND...
- Publication number 20110160176
- Publication date Jun 30, 2011
- ABBOTT GmbH & Co. KG
- Karla Drescher
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Arylsulfonylmethyl or arylsulfonamide substituted aromatic compound...
- Publication number 20090012074
- Publication date Jan 8, 2009
- Karla Drescher
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterocyclic Compounds Suitable For Treating Disorders That Respond...
- Publication number 20080045493
- Publication date Feb 21, 2008
- Karla Drescher
- C07 - ORGANIC CHEMISTRY

Christophe Henry

Person

Patents Grantslast 30 patents

Substituted imidazoquinolines

Substituted imidazoquinolines as agonists of TLR7

Substituted imidazoquinolines as agonists of TLR7

Substituted imidazoquinolines

Arylsulfonylmethyl or arylsulfonamide substituted aromatic compound...

Heterocyclic compounds suitable for treating disorders that respond...

Heterocyclic compounds suitable for treating disorders that respond...

Patents Applicationslast 30 patents

SUBSTITUTED IMIDAZOQUINOLINES AS AGONISTS OF TLR7

SUBSTITUTED IMIDAZOQUINOLINES

PROCESS FOR THE PREPARATION OF A SUBSTITUTED IMIDAZOQUINOLINE

SUBSTITUTED IMIDAZOQUINOLINES AS AGONISTS OF TLR7

SUBSTITUTED IMIDAZOQUINOLINES

HETEROCYCLIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND...

Arylsulfonylmethyl or arylsulfonamide substituted aromatic compound...

Heterocyclic Compounds Suitable For Treating Disorders That Respond...